JOHN GILL Insider Trading $ALT Altimmune, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN GILL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN GILL. JOHN GILL is Director in PHARMATHENE, INC ($PIP) and President and CEO in PHARMATHENE, INC ($PIP).
JOHN GILL in Altimmune, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN GILL: President and CEO, Director
Holdings: 11,199 shares
Current Value: $15,343
Latest Transaction: Dec 02 2020
$ALT Market Capitalization: $76.74M
$ALT Previous Close: $1.37
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JOHN GILL in Altimmune, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 02 2020 | ALT | Altimmune, Inc. | GILL JOHN | Director | Sell | S | 11.92 | 8,425 | 100,426 | 11,199 | 19.6 K to 11.2 K (-42.93 %) |
| Oct 16 2020 | ALT | Altimmune, Inc. | GILL JOHN | Director | Option Exercise | M | 0.00 | 16,850 | 0 | 0 | |
| Oct 16 2020 | ALT | Altimmune, Inc. | GILL JOHN | Director | Buy | M | 0.00 | 16,850 | 0 | 19,624 | 2.8 K to 19.6 K (+607.43 %) |
| Sep 28 2020 | ALT | Altimmune, Inc. | GILL JOHN | Director | Option Exercise | A | 12.03 | 25,500 | 306,765 | 25,500 | |
| Jun 29 2020 | ALT | Altimmune, Inc. | GILL JOHN | Director | Option Exercise | A | 0.00 | 16,850 | 0 | 16,850 | |
| Jun 29 2020 | ALT | Altimmune, Inc. | GILL JOHN | Director | Option Exercise | A | 0.00 | 16,850 | 0 | 16,850 | |
| Jan 04 2019 | ALT | Altimmune, Inc. | GILL JOHN | Director | Option Exercise | A | 2.60 | 20,000 | 52,000 | 20,000 | |
| Oct 17 2017 | PIP | Altimmune, Inc. | GILL JOHN | Director | Option Exercise | A | 2.50 | 20,000 | 50,000 | 20,000 | |
| Jun 06 2017 | PIP | Altimmune, Inc. | GILL JOHN | Director | Buy | P | 4.34 | 1,000 | 4,344 | 83,224 | 82.2 K to 83.2 K (+1.22 %) |
| Nov 23 2016 | PIP | PHARMATHENE, INC | GILL JOHN | President and CEO | Option Exercise | M | 2.20 | 100,000 | 220,000 | 0 | |
| Nov 23 2016 | PIP | PHARMATHENE, INC | GILL JOHN | President and CEO | Buy | M | 2.20 | 100,000 | 220,000 | 822,244 | 722.2 K to 822.2 K (+13.85 %) |
| Sep 19 2016 | PIP | PHARMATHENE, INC | GILL JOHN | President and CEO | Option Exercise | M | 2.47 | 20,000 | 49,400 | 0 | |
| Sep 19 2016 | PIP | PHARMATHENE, INC | GILL JOHN | President and CEO | Option Exercise | M | 2.59 | 10,000 | 25,900 | 0 | |
| Sep 19 2016 | PIP | PHARMATHENE, INC | GILL JOHN | President and CEO | Option Exercise | M | 1.51 | 20,000 | 30,200 | 0 | |
| Sep 19 2016 | PIP | PHARMATHENE, INC | GILL JOHN | President and CEO | Option Exercise | M | 1.64 | 20,000 | 32,800 | 0 | |
| Sep 19 2016 | PIP | PHARMATHENE, INC | GILL JOHN | President and CEO | Option Exercise | M | 1.45 | 20,000 | 29,000 | 0 | |
| Sep 19 2016 | PIP | PHARMATHENE, INC | GILL JOHN | President and CEO | Option Exercise | M | 1.60 | 20,000 | 32,000 | 0 | |
| Sep 19 2016 | PIP | PHARMATHENE, INC | GILL JOHN | President and CEO | Buy | M | 2.47 | 20,000 | 49,400 | 722,244 | 702.2 K to 722.2 K (+2.85 %) |
| Sep 19 2016 | PIP | PHARMATHENE, INC | GILL JOHN | President and CEO | Buy | M | 2.59 | 10,000 | 25,900 | 702,244 | 692.2 K to 702.2 K (+1.44 %) |
| Sep 19 2016 | PIP | PHARMATHENE, INC | GILL JOHN | President and CEO | Buy | M | 1.51 | 20,000 | 30,200 | 692,244 | 672.2 K to 692.2 K (+2.98 %) |
| Sep 19 2016 | PIP | PHARMATHENE, INC | GILL JOHN | President and CEO | Buy | M | 1.64 | 20,000 | 32,800 | 672,244 | 652.2 K to 672.2 K (+3.07 %) |
| Sep 19 2016 | PIP | PHARMATHENE, INC | GILL JOHN | President and CEO | Buy | M | 1.45 | 20,000 | 29,000 | 652,244 | 632.2 K to 652.2 K (+3.16 %) |
| Sep 19 2016 | PIP | PHARMATHENE, INC | GILL JOHN | President and CEO | Buy | M | 1.60 | 20,000 | 32,000 | 632,244 | 612.2 K to 632.2 K (+3.27 %) |
| Jun 03 2016 | PIP | PHARMATHENE, INC | GILL JOHN | President and CEO | Option Exercise | A | 2.20 | 100,000 | 220,000 | 100,000 | |
| Nov 09 2015 | PIP | PHARMATHENE, INC | GILL JOHN | President and CEO | Grant | A | 0.00 | 612,244 | 0 | 612,244 | 0 to 612.2 K |
| Jun 13 2013 | PIP | PHARMATHENE, INC | GILL JOHN | Director | Option Exercise | A | 1.64 | 20,000 | 32,800 | 20,000 | |
| Jun 26 2012 | PIP | PHARMATHENE, INC | GILL JOHN | Director | Option Exercise | A | 1.45 | 20,000 | 29,000 | 20,000 | |
| Jun 27 2011 | PIP | PHARMATHENE, INC | GILL JOHN | Director | Option Exercise | A | 3.11 | 20,000 | 62,200 | 20,000 | |
| Jun 25 2010 | PIP | PHARMATHENE, INC | GILL JOHN | Director | Option Exercise | A | 1.60 | 20,000 | 32,000 | 20,000 | |
| Oct 11 2007 | PIP | PHARMATHENE, INC | GILL JOHN | Director | Option Exercise | P | 5.25 | 20,000 | 105,000 | 20,000 |
Page: 1